Cipla (CIPLA)

BSE · INR

N/AN/A (N/A)
Market closed · Last known quote: Sep 10, 2026, 6:27 PM GMT+0530

Cipla Chart

People also watch

Related in Pharmaceuticals

About Cipla

Healthcare · Pharmaceuticals · Mumbai · India · Founded 1 Jan 1935

Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the…

Founded byKhwaja Abdul Hamied

WikipediaWikidata organisationCompany website

Financial statistics

Share Statistics

Shares Outstanding807.00M

Technical analysis

Summary Sell Last price is below the short and medium moving averages. RSI 81.5, MACD negative. Trend: sideways.
TrendSideways
RSI (14)81.5
MACD-0.021
SMA 20₹99.54
SMA 50₹99.66
SMA 200₹99.76
Support₹99.42
Resistance₹100.00
Stochastic %K97.9
ATR (14)0.090
IndicatorCallDetail
Price vs SMA 20 Buy Last close is above the 20-session average.
Price vs SMA 50 Buy Medium-term trend is still up.
SMA cross Sell The 20-session average is below the 50-session average.
RSI (14) Sell RSI is overbought above 70.
MACD Sell MACD line is below zero.
Stochastic Sell Stochastic %K is overbought.

Company profile

SectorHealthcare
IndustryPharmaceuticals
EmployeesN/A
CEON/A
HeadquartersMumbai
CountryIndia
Founded1 Jan 1935
Legal formjoint-stock company
OrganisationIndian multi-national pharmaceutical and biotechnology company
Website www.cipla.com

Historical price data

Currency in INR
DateOpenHighLowCloseVolume
Loading recent price history

News & official updates

Price quotes and the 1D chart refresh every few seconds while this page stays open — no reload needed. Last trade is taken from the exchange feed where available; some venues delay 0–15 minutes. When the market is closed, the last recorded session price is shown. Fundamentals refresh on a slower schedule.